Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Apr 10, 2014
THE CANADIAN BIOMARKERS IN DEPRESSION INTEGRATED DISCOVERY PROGRAM: CAN-BIND
The Canadian Biomarkers in Depression (CAN-BIND) Integrated Discovery Program is a research-based innovative initiative designed to improve the diagnosis and treatment of depression. The program's mandate is to ensure that discoveries are transformed into new diagnostics, treatments and improved clinical practice. The emphasis is on translational science and involves a province-wide collaboration between Ontario's world-class depression researchers and clinicians, patient advocacy groups and the industrial sector. This collaborative initiative is also engaging partner sites across Canada in an effort to bridge the translational gap and to better predict treatment selection and outcomes. The goal of CAN-BIND is to develop tools to get patients the right treatment the first time.